Abstract
Polycystic Ovary Syndrome (PCOS) has been associated with insulin resistance, hypertension and dyslipidemia, which are responsible for the increase in cardiovascular risk. However, a subgroup of patients does not present these metabolic disturbances, being classified as 'metabolic health'. Studies with the objective to differentiate such patients from the ones with metabolic compromising …